By Job Title:

CEO, CSO, MDs, VPs, Directors & Heads

• Business Development & Strategy
• Research and Development
• Strategic Alliances
• Commercial Development
• Branding
• IP /Counsel Lawyer & Patent Attorney
• Sales & Marketing
• Regulatory Affairs
• Product Development
• Strategy / Corporate Planning & Development
• Licensing
• Procurement / Sourcing
• External Manufacturing
• Collaborative Research
• CMO Account Management
• External Resourcing
• Quality Assurance
• Technology Transfer

Recent attendees of IBC’s Generics and Biosimilars series include:
ASTRAZENECA, GENENTECH INC, BECTON DICKINSON, BOEHRINGER INGELHEIM GMBH, GLAXOSMITHKLINE, HOSPIRA, MERCK & CO, DR REDDY'S LABORATORIES, PFIZER, NIPPON KAYAKU, RANBAXY, CENTRUM CAPITAL, DRUG HOUSES OF AUSTRALIA, JCR PHARMACEUTICALS, BAYER, USV, NORTH CHINA PHARMACEUTICAL GROUP CORPORATION, HANWHA CHEMICAL, MATRIX LABS, PHARMANIAGA, HOVID, UNITED LABORATORIES INC, PT DEXA MEDICA, SANOFI-AVENTIS, WOCKHARDT, ZUELLIG PHARMA, ACTAVIS, PHARMANIAGA, BAYER, PFIZER, ELI LILLY, TAKEDA, SANDOZ, HISUN PHARMACEUTICAL, AUROBINDO PHARMA, SUNWARD PHARMACEUTICAL, NECTAR LIFESCIENCES, CCM DUOPHARMA, PT DEXA MEDICA, ALLERGAN, FERRING PHARMACEUTICALS, Y S P SOUTHEAST ASIA HOLDINGS BHD, WEST PHARMACEUTICAL, MERCK SHARPE & DOME, ABBOTT LABORATORIES, STADA PHARMACEUTICALS, DAIICHI SANKYO, GENZYME, COBEL DAROU, XIAN-JANSSEN PHARM, SAMSUNG, GETZ PHARMACEUTICAL, ZHEJIANG GOLDPHARMA, JIANGSU CHIA TAI TIANQING PHARMACEUTICAL, LG LIFE SCIENCES